Send Message
ANHUI BBCA PHARMACEUTICAL CO.,LTD
ANHUI BBCA PHARMACEUTICAL CO.,LTD
products
Home /

products

Calcium Antagonists Cardiovascular Drugs Cilnidipine Tablets 5mg 10mg To Treat Hypertension

Product Details

Certification: GMP

Model Number: BBCA18011530

Payment & Shipping Terms

Price: Negotiated

Packaging Details: 14 Tablets/box, 200 Boxes/Carton

Delivery Time: 25 DAYS AFTER PAYMENT

Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram

Get Best Price
Contact Now
Specifications
Highlight:

cilnidipine tablets

,

naftopidil tablets

Place Of Origin:
China (Mainland)
Brand Name:
BBCA
Other Names:
Made In China Cilnidipine Tablets
Grade:
Medicine Grade
Dosage Form:
Injection
Place Of Origin:
China (Mainland)
Brand Name:
BBCA
Other Names:
Made In China Cilnidipine Tablets
Grade:
Medicine Grade
Dosage Form:
Injection
Description
Calcium Antagonists Cardiovascular Drugs Cilnidipine Tablets 5mg 10mg To Treat Hypertension

Calcium Antagonists Cilnidipine Tablets 5mg 10mg To Treat Hypertension

Specifications

 

Cilnidipine Tablets

Type: Calcium Antagonists

Usage: Treatment for hypertension patients

Packing: 14TabletsX100Boxes/Carton

GMP Certified

Standard: 5mg

Original: China

Manufacture: ANHUI BBCA PHARMRACEUTICAL Co., Ltd.

 

Cilnidipine decreases blood pressure and is used to treat hypertension and its comorbidities. Due to its blocking action at the N-type and L-type calcium channel, cilnidipine dilates both arterioles and venules, reducing the pressure in the capillary bed. Cilnidipine is vasoselective and has a weak direct dromotropic effect, a strong vasodepressor effect, and an arrhythmia-inhibiting effect. Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients  - the results of a large-scale prospective post-marketing surveillance study of post-stroke hypertensive patients (n = 2667, male 60.4%, 69.0 ± 10.9 years) treated with cilnidipine indicate that ilnidipine was effective in treating uncontrolled blood pressure and was well tolerated in post-stroke hypertensive patients.The Ambulatory Blood Pressure Control and Home Blood Pressure (Morning and Evening) Lowering By N-Channel Blocker Cilnidipine  trial is a large-scale (n=2319) clinical study on blood pressure (BP) and pulse rate (PR) in the real world with use of cilnidipine - this study revealed that Cilnidipine significantly reduced BP and PR in hypertensive patients at the clinic and at home, especially with higher BP and PR in the morning.

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send